Umbralisib Plus Ublituximab (U2) Is Superior To Obinutuzumab Plus Chlorambucil (O Plus Chl) In Patients With Treatment Naive (Tn) And Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (Cll): Results From The Phase 3 Unity-Cll StudyJohn G. Gribben,Wojciech Jurczak,Ryan W. Jacobs,Sebastian Grosicki,Krzysztof Giannopoulos,Tomasz Wrobel,Syed F. Zafar,Jennifer L. Cultrera,Suman Kambhampati,Alexey Danilov,John M. Burke,Jerome Goldschmidt,Douglas F. Beach,Scott F. Huntington,Javier Pinilla Ibarz,Jeff P Sharman,Tanya Siddiqi,Danielle M. Brander,John M. Pagel,Kathryn S. Kolibaba,Monika Dlugosz-Danecka,Nilanjan Ghosh,Peter Sportelli,Hari P. Miskin,Owen A. O'Connor,Michael S. Weiss,Ian W. FlinnBLOOD(2020)引用 58|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要